Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine-induced neuroplasticity in first-episode schizophrenia
2007-000545-35Phase 4Completed
- Sponsor
- medbo
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in schizophrenia, sponsored by medbo. Primary endpoint: Change in gray matter density by VBM. Started Sep 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-000545-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000545-35.